SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001016169-22-000044
Filing Date
2022-05-10
Accepted
2022-05-10 17:13:46
Documents
64
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q atrs-20220331.htm   iXBRL 10-Q 1014349
2 EX-31.1 atrs-20220331x10qexx311.htm EX-31.1 10305
3 EX-31.2 atrs-20220331x10qexx312.htm EX-31.2 10336
4 EX-32.1 atrs-20220331x10qexx321.htm EX-32.1 5423
5 EX-32.2 atrs-20220331x10qexx322.htm EX-32.2 5435
11 GRAPHIC atrs-20220331_g1.jpg GRAPHIC 48666
  Complete submission text file 0001016169-22-000044.txt   5240837

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT atrs-20220331.xsd EX-101.SCH 39010
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT atrs-20220331_cal.xml EX-101.CAL 53473
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT atrs-20220331_def.xml EX-101.DEF 186633
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT atrs-20220331_lab.xml EX-101.LAB 509333
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT atrs-20220331_pre.xml EX-101.PRE 314591
58 EXTRACTED XBRL INSTANCE DOCUMENT atrs-20220331_htm.xml XML 693543
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32302 | Film No.: 22910984
SIC: 3841 Surgical & Medical Instruments & Apparatus